DDD — 3D Systems Corporation

3D Systems Q1 2026 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: Consolidated revenue for Q1 2026 was $95.5 million, an 11% increase year-over-year.
• Segment Performance:
  • Healthcare Solutions: Revenue of $50.1 million, up 21% year-over-year, driven by strong growth in Dental and Med Tech.
  • Industrial Solutions: Revenue of $45.4 million, a modest increase of 1.6% year-over-year, with Aerospace & Defense showing over 20% growth.
• Gross Margin: Non-GAAP gross margin improved to 36.1%, up 6 percentage points from the prior year.
• Operating Expenses: Non-GAAP operating expenses decreased by 35% year-over-year to $36.6 million.
• Adjusted EBITDA: Positive $2.1 million, an improvement of $26 million year-over-year.
• Earnings Per Share: Non-GAAP loss per share improved to $0.01 from a loss of $0.21 in the prior year.

2. Strategic Updates and Business Highlights

• Product Portfolio: Introduction of a refreshed product line, including new metal and polymer printers, is driving growth.
• Market Focus: Targeted investments in Aerospace & Defense, Med Tech, and Dental markets are yielding positive results.
• Dental Market: Strong growth in dental materials and successful launch of the NextDent 300 denture printing system, which has received regulatory approvals in the U.S. and EU.
• Aerospace & Defense: Significant growth driven by demand for high-reliability metal components, with plans for an 80,000 square foot expansion in Littleton, Colorado, to enhance production capabilities.

3. Forward Guidance and Outlook

• Q2 Revenue Guidance: Expected to be between $93 million and $95 million, reflecting normal seasonal trends.
• Adjusted EBITDA Guidance: Anticipated loss in the range of $2 million to $4 million for Q2.
• Long-term Outlook: Management remains optimistic about continued growth in key markets, aiming for breakeven adjusted EBITDA or better for the full year.

4. Bad News, Challenges, or Points of Concern

• Customer Disruption: A temporary disruption in operations at a key customer impacted sales, although recovery is expected in Q2.
• Geopolitical Risks: Ongoing conflicts, particularly in the Middle East, are causing logistical challenges and could affect customer demand and supply chain stability.
• Seasonal Variability: Anticipated seasonal declines in Q2 due to customer behavior around vacations and elective procedures.

5. Notable Q&A Insights

• Positive Tone: CEO Jeffrey Graves expressed optimism about the company’s growth trajectory, attributing it to successful R&D investments and a recovering market.
• Market Dynamics: Strong demand across Healthcare and Industrial sectors, particularly in Aerospace & Defense, is noted as a key growth driver.
• Cautious Approach: Management emphasized a measured outlook due to global volatility and potential supply chain disruptions, urging caution in revenue expectations.
• Healthcare Growth: Both personalized healthcare and dental segments are performing well, with a focus on orthopedic and oncology applications driving Med Tech growth.
• Expansion Plans: The new facility in Littleton is expected to support increased production of high-end metal components, addressing growing demand in Aerospace & Defense.

Overall, 3D Systems reported a strong first quarter with significant growth across key markets, although challenges remain in customer operations and geopolitical factors. The company is strategically positioned for continued growth, particularly in the healthcare and aerospace sectors.